Pre-procedural CT angiography inferior vena cava measurements: a predictor of mortality in patients undergoing transcatheter aortic valve implantation
- 114 Downloads
To assess the value of pre-procedural computed tomography angiography (CTA) measurements of the suprahepatic inferior vena cava (IVC) to detect elevated central venous pressure (CVP) assessed by right heart catheterisation (RHC), and to predict post-procedural 1-year mortality in a cohort of patients undergoing transcatheter aortic valve implantation (TAVI).
We retrospectively evaluated 408 consecutive patients undergoing CTA before TAVI between January 2011 and December 2014. Two hundred and five patients were included in the RHC cohort, who underwent RHC and CTA within ≤1 day prior to TAVI. Two hundred and three patients not fulfilling this requirement were included in the validation cohort. Measurements of the IVC were performed between diaphragm and right atrium on axial slices. Receiver operating characteristic (ROC) analyses, Kaplan-Meier analyses and Cox regression analyses were performed.
In the RHC cohort, ROC curve analyses for IVC area measurements indicated an AUC of 0.77 (p < 0.001) to detect CVP ≥10mmHg and an area under the ROC curve (AUC) of 0.72 (p < 0.001) to predict 1-year mortality. An IVC area cut-off of ≥665 mm2 predicted 1-year mortality with a specificity of 84% and a sensitivity of 63%. Kaplan-Meier analysis showed that patients with an IVC area ≥665 mm2 had a significantly higher post-procedural 1-year mortality (38% versus 7%, log-rank p < 0.001) with a hazard ratio of 5.5 (95% CI, 2.2-13.6; p < 0.001). Applying this cut-off value to the validation cohort confirmed a significantly higher 1-year mortality after TAVI (34% versus 11%; log-rank p = 0.004) for patients with an IVC area ≥665 mm2.
Pre-procedural enlargement of the suprahepatic IVC is a predictor of post-procedural 1-year mortality in patients evaluated for TAVI.
• IVC measurements are moderate predictors of an elevated CVP in TAVI patients.
• Pre-procedural IVC enlargement is a predictor of 1-year mortality after TAVI.
• IVC enlargement is associated with right heart dysfunction in TAVI patients.
KeywordsAortic valve stenosis Central venous pressure Computed tomography angiography Vena cava; inferior Transcatheter aortic valve replacement
Body surface area
Central venous pressure
Inferior vena cava
Pulmonary capillary wedge pressure
Right heart catheterisation
Transcatheter aortic valve implantation
We thank Gillian von Rechenberg for language and punctuation revision of our manuscript.
The authors state that this work has not received any funding.
Compliance with ethical standards
The scientific guarantor of this publication is Thi Dan Linh Nguyen-Kim.
Conflict of interest
The authors of this manuscript declare relationships with the following companies:
Francesco Maisano is consultant for Abbott Vascular, St Jude Medical, Medtronic, ValtechCardio and receives royalties from Edwards Lifesciences.
Fabian Nietlispach is consultant for Edwards Lifesciences, Medtronic, St Jude Medical.
Thi Dan Linh Nguyen-Kim is funded by the research grant “Filling the gap” from the University of Zurich, Switzerland.
All other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Written informed consent was obtained from all subjects (patients) in this study.
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Some study subjects or cohorts have been previously reported in:
1. Eberhard M, Mastalerz M, Frauenfelder T et al (2017) Quantification of aortic valve calcification on contrast-enhanced CT of patients prior to transcatheter aortic valve implantation. EuroIntervention 13:921-927
2. Eberhard M, Mastalerz M, Pavicevic J et al (2017) Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis. Int J Cardiovasc Imaging 33:1637-1651
3. Possner M, Vontobel J, Nguyen-Kim TD et al (2016) Prognostic value of aortic regurgitation after AVI in patients with chronic kidney disease. Int J Cardiol 221:180-187
4. Stahli BE, Abouelnour A, Nguyen TD et al (2014) Impact of three-dimensional imaging and pressure recovery on echocardiographic evaluation of severe aortic stenosis: a pilot study. Echocardiography 31:1006-1016
While the previous studies assessed quantification of aortic valve calcification, prognostic value of aortic regurgitation after TAVI, impact of three-dimensional imaging and pressure recovery on echocardiographic evaluation of severe aortic stenosis and value of previously reported CT signs and measurements as a predictor of pulmonary hypertension and mortality in severe aortic stenosis, this work focused on whether IVC measurements are correlated with central venous pressure and the predictive value of IVC measurements on one-year mortality after TAVI. Thus, this work is substantially different from the previous reports. Additionally, in contrast to the aforementioned studies the present study is the only one including all patients undergoing TAVI between 01/2011 and 12/2014 at our institution.
• diagnostic or prognostic study
• performed at one institution
- 3.Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:2440–2492CrossRefGoogle Scholar
- 17.Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713 quiz 786-688CrossRefGoogle Scholar
- 22.Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T, Investigators E (2009) Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J 157:1026–1034CrossRefGoogle Scholar
- 24.O'Sullivan CJ, Wenaweser P, Ceylan O et al (2015) Effect of pulmonary hypertension haemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv 8:e002358Google Scholar
- 25.Chrissoheris M, Ziakas A, Chalapas A et al (2016) Acute invasive haemodynamic effects of transcatheter aortic valve replacement. J Heart Valve Dis 25:162–172Google Scholar
- 28.Franzone A, O'Sullivan CJ, Stortecky S et al (2017) Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation. EuroIntervention 12:e2186–e2193CrossRefGoogle Scholar
- 29.Natori H, Tamaki S, Kira S (1979) Ultrasonographic evaluation of ventilatory effect on inferior vena caval configuration. Am Rev Respir Dis 120:421–427Google Scholar